MedPath
HSA Product

MALTOFER DROPS 50 mg/ml

Product approved by Health Sciences Authority (SG)

Basic Information

MALTOFER DROPS 50 mg/ml

SOLUTION

Regulatory Information

SIN05699P

April 8, 1991

General Sale List

Therapeutic

ORAL

August 10, 2023

June 3, 2025

XB03AB05

Company Information

VIFOR SA

VIFOR PHARMA ASIA PACIFIC PTE. LTD.

VIFOR PHARMA ASIA PACIFIC PTE. LTD.

Active Ingredients

Detailed Information

Contraindications

**Contraindications** - Known hypersensitivity or intolerance to iron(III)-hydroxide polymaltose complex or any of the excipients - Iron overload (e.g. haemochromatosis, haemosiderosis) - Disturbances in iron utilisation (e.g. anaemia from lead-poisoning, sidero-achrestic anaemia, thalassaemia) - Anaemia not caused by iron deficiency (e.g. haemolytic anaemia or megaloblastic anaemia due to vitamin B12 deficiency).

Indication Information

**Therapeutic indications** Treatment of iron deficiency without anaemia and iron deficiency anaemia. Prophylactic therapy of iron deficiency to cover the recommended daily dietary allowances (RDA) during pregnancy and lactation, for children, adolescents and adults (e.g. vegetarians and elderly).

© Copyright 2025. All Rights Reserved by MedPath